Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organon & Co. (NY: OGN )

20.27 +0.51 (+2.58%)
Streaming Delayed Price Updated: 1:28 PM EDT, Jun 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,037,484
Open 19.80
Bid (Size) 20.26 (5)
Ask (Size) 20.27 (2)
Prev. Close 19.76
Today's Range 19.77 - 20.34
52wk Range 18.87 - 38.09
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Stocks That Are Long Overdue for a Relief Rally
Here are seven stocks with the catalysts and fundamentals to support a sustained relief rally in this environment. 
Via InvestorPlace
Daily Stock Analysis: Organon & Co
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions. 
Via Talk Markets

Performance

YTD
-27.79%
-27.79%
1 Month
-9.99%
-9.99%
3 Month
-15.96%
-15.96%
6 Month
-23.07%
-23.07%
1 Year
-45.90%
-45.90%

More News

Read More
Organon's Return On Capital Employed Insights
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Check Out 3 Health Care Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts
Via Benzinga
Organon Reports Results for the First Quarter Ended March 31, 2023
From Organon & Co.
Via Business Wire
Organon's Earnings: A Preview
Via Benzinga
Organon: Dividend Insights
Via Benzinga
Why Shares of Organon Fell 15% Thursday
Via The Motley Fool
Organon To Report First Quarter and Host Conference Call on May 4, 2023
From Organon & Co.
Via Business Wire
7 Growth Stocks That Are Trading at a Bargain Price
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
Via Benzinga
Earnings Scheduled For February 16, 2023
Via Benzinga
Earnings Preview For Organon
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist
From Organon & Co.
Via Business Wire
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022
From Organon
Via Business Wire
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023
From Organon & Co.
Via Business Wire
AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff
Via Investor's Business Daily
'It's The Only China Stock I'd Buy': Cramer On This E-Commerce Stock
Via Benzinga
Organon Stock Scores Market Leadership With Jump To 83 RS Rating
Via Investor's Business Daily
Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy
From Organon & Co.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.